ZHU Qing-qing,LI Xue-ling,YAN Jia-yi,et al.Protection mechanism of Puerarin on H2O2-induced oxidative stress and mitochondrial damage in human podocytes under high glucose environment[J]. Beijing Journal of Traditional Chinese Medicine,2022,41(02):125-131.
ZHU Qing-qing,LI Xue-ling,YAN Jia-yi,et al.Protection mechanism of Puerarin on H2O2-induced oxidative stress and mitochondrial damage in human podocytes under high glucose environment[J]. Beijing Journal of Traditional Chinese Medicine,2022,41(02):125-131. DOI: 10.16025/j.1674-1307.2022.02.004.
Protection mechanism of Puerarin on H2O2-induced oxidative stress and mitochondrial damage in human podocytes under high glucose environment
Objective,2,To explore the effect of puerarin on oxidative stress and mitochondrial damage in human immortal podocytes induced by H,2,O,2, under high glucose environment and its mechanism.,Methods,2,Human immortal podocytes were stimulated with different concentrations of H,2,O,2, in a high-glucose environment, and intervened by different concentrations of puerarin for 48 hours. The groups were divided as follows: group H0 (H,2,O,2, 0 μmol/L), group H100 (H,2,O,2, 100 μmol/L), group H100+P3.3(H,2,O,2 ,100 μmol/L+ puerarin 3.3 μmol/L), group H100+ P10 (H,2,O,2, 100 μmol/L+ puerarin 10 μmol/L), group H200 (H,2,O,2, 200 μmol/L), group H200+P3.3(H,2,O,2, 200 μmol/L+ puerarin 3.3 μmol/L), group H200+P10(H,2,O,2, 200 μmol/L+puerarin 10 μmol/L). CCK-8 was used to detect cell viability. Western blotting was used to detect the protein expression of TOMM22; Genomic DNA was extracted and qPCR was used to detect the expression of mtDNA; RNA was extracted and qPCR was used to detect the mRNA expression of TFAM and NRF1;the levels of ATP and ROS in each group were measured and the mitochondrial respiratory function were evaluated.,Results,2,Compared with H0 group, ROS level was increased in H100 and H200 groups (,P,<,0.01), mtDNA copy number was decreased in H100 and H100+P3.3 groups (,P,<,0.01), TFAM mRNA expression was decreased, basal respiration, proton leakage, maximum oxygen consumption and non-mitochondrial oxygen consumption were increased (,P,<,0.05). Compared with H100 group, ROS in H100+P3.3 group was decreased (,P,<,0.05), TFAM mRNA and NRF1 mRNA expression were increased (,P,<,0.05,P,<,0.01), ATP production was increased (,P,<,0.05), basal respiration and proton leakage were decreased (,P,<,0.05) in group H100+P3.3. In H100+P10 group, mtDNA copy number was increased (,P,<,0.05), NRF1 mRNA, basal respiration, proton leakage and non-mitochondrial consumption were increased (,P,<,0.05). Compared with H100+P3.3 group, the mtDNA copy number of H100+P10 group was significantly increased (,P,<,0.01), basal respiration, proton leakage, non-mitochondrial oxygen consumption and ATP levels were increased (,P,<,0.05). Compared with H200 group, ROS levels in H200+P3.3 and H200+P10 groups were significantly decreased (,P,<,0.01), NRF1 mRNA expression was increased (,P,<,0.01) and non-mitochondrial oxygen consumption was increased (,P,<,0.05) in H200+P10 group. Compared with H200+P3.3 group, ROS level in H200+P10 group increased (,P,<,0.01), TFAM mRNA expression increased (,P,<,0.05), NRF1 mRNA expression increased (,P,<,0.01). There were no statistically significant differences in TOMM22 protein expression, reserve respiratory capacity, coupling efficiency and reserve respiratory rate among all groups (,P,>,0.05).,Conclusion,2,Puerarin can partially relieve podocyte oxidative stress and mitochondrial damage induced by high glucose and H,2,O,2,.
MAGLIANO DJ,ISLAM RM,BARR ELM,et al.Trends in incidence of total or type 2 diabetes:systematic review[J].BMJ Clin Res Ed,2019,366:l5003.
MOLITCH ME,ADLER AI,FLYVBJERG A,et al.Diabetic kidney disease:a clinical update from Kidney Disease:Improving Global Outcomes[J].Kidney Int,2015,87(1):20-30.
ZHANG LX,LONG JY,JIANG WS,et al.Trends in chronic kidney disease in China[J].N Engl J Med,2016,375(9):905-906.
THOMAS MC,COOPER ME,ZIMMET P.Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease[J].Nat Rev Nephrol,2016,12(2):73-81.
TANAMAS SK,SAULNIER PJ,FUFAA GD,et al.Long-term effect of losartan on kidney disease in American indians with type 2 diabetes:a follow-up analysis of a randomized clinical trial[J].Diabetes Care,2016,39(11):2004-2010.
DUAN HJ,LIU SX,ZHANG YJ,et al.Effects of puerarin on renal function,expressions of MMP-2 and TIMP-2 in diabetic rats[J].Acta Pharm Sin,2004,39(7):481-485.
WANG B,CHEN SB,YAN XF,et al.The therapeutic effect and possible harm of puerarin for treatment of stage III diabetic nephropathy:a meta-analysis[J].Altern Ther Health Med,2015,21(1):36-44.
SONG XB,LIU G,WANG ZY,et al.Puerarin protects against cadmium-induced proximal tubular cell apoptosis by restoring mitochondrial function[J].Chem Biol Interact,2016,260:219-231.
WANG ZK,ZHOU XL,SONG XB,et al.Alleviation of lead-induced apoptosis by puerarin via inhibiting mitochondrial permeability transition pore opening in primary cultures of rat proximal tubular cells[J].Biol Trace Elem Res,2016,174(1):166-176.
ZHONG YF,ZHANG XW,CAI XF,et al.Puerarin attenuated early diabetic kidney injury through down-regulation of matrix metalloproteinase 9 in streptozotocin-induced diabetic rats[J].PLoS One,2014,9(1):e85690.
LI X,CAI W,LEE K,et al.Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes[J].Sci Rep,2017,7(1):14603.
LI XL,ZHU QQ,ZHENG R,et al.Puerarin attenuates diabetic nephropathy by promoting autophagy in podocytes[J].Front Physiol,2020,11:73.
MANIURA-WEBER K,GOFFART S,GARSTKA HL,et al.Transient overexpression of mitochondrial transcription factor A (TFAM) is sufficient to stimulate mitochondrial DNA transcription,but not sufficient to increase mtDNA copy number in cultured cells[J].Nucleic Acids Res,2004,32(20):6015-6027.
PATTI ME,BUTTE AJ,CRUNKHORN S,et al.Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes:Potential role of PGC1 and NRF1[J].Proc Natl Acad Sci USA,2003,100(14):8466-8471.